Stock AAREYDRUGS AAREY DRUGS & PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Aarey Drugs & Pharmaceuticals Limited

Equities

AAREYDRUGS

INE198H01019

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 11:00:53 14/06/2024 BST 		5-day change 1st Jan Change
47.69 INR +0.40% Intraday chart for Aarey Drugs & Pharmaceuticals Limited +3.90% -5.62%
05-30 Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
03-27 Aarey Drugs & Pharmaceuticals Limited announced that it has received INR 106.581598 million in funding from Black Hawk Properties Private Limited, Rajan Dental Institute Private Limited, Marygold Health And Education Private Limited, Riddhi Trade Solutions Private Limited, Karan Monomer's Private Limited, Watco Chennai Real Estates Private Limited and other investors CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 1,259 675.8 311 542.5 1,051 600.9
Enterprise Value (EV) 1 1,258 833.7 484.9 716.2 1,191 966.8
P/E ratio 20.4 x 10.3 x 5.37 x 8.33 x 15.2 x 15.9 x
Yield - 0.35% - - - -
Capitalization / Revenue 0.36 x 0.19 x 0.1 x 0.15 x 0.21 x 0.14 x
EV / Revenue 0.36 x 0.23 x 0.16 x 0.2 x 0.24 x 0.23 x
EV / EBITDA 15.3 x 8.22 x 6.69 x 7.83 x 9.95 x 11.7 x
EV / FCF -7.09 x -4.61 x -10.9 x -24.2 x -267 x -3.35 x
FCF Yield -14.1% -21.7% -9.14% -4.14% -0.37% -29.9%
Price to Book 1.57 x 0.78 x 0.34 x 0.55 x 0.92 x 0.51 x
Nbr of stocks (in thousands) 23,385 23,385 23,385 23,385 25,385 25,385
Reference price 2 53.85 28.90 13.30 23.20 41.40 23.67
Announcement Date 30/08/18 09/09/19 05/12/20 20/08/21 07/09/22 12/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 3,493 3,562 3,009 3,514 4,929 4,190
EBITDA 1 82.39 101.4 72.48 91.51 119.7 82.66
EBIT 1 75.27 91.29 63.54 82.31 99.79 66.92
Operating Margin 2.15% 2.56% 2.11% 2.34% 2.02% 1.6%
Earnings before Tax (EBT) 1 81.92 89.86 72.42 83.01 100.3 60.1
Net income 1 61.78 65.42 57.94 65.14 65.45 37.71
Net margin 1.77% 1.84% 1.93% 1.85% 1.33% 0.9%
EPS 2 2.640 2.797 2.477 2.786 2.718 1.486
Free Cash Flow 1 -177.4 -180.7 -44.32 -29.65 -4.464 -288.6
FCF margin -5.08% -5.07% -1.47% -0.84% -0.09% -6.89%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - 0.1000 - - - -
Announcement Date 30/08/18 09/09/19 05/12/20 20/08/21 07/09/22 12/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - 158 174 174 140 366
Net Cash position 1 1.54 - - - - -
Leverage (Debt/EBITDA) - 1.557 x 2.399 x 1.898 x 1.167 x 4.427 x
Free Cash Flow 1 -177 -181 -44.3 -29.6 -4.46 -289
ROE (net income / shareholders' equity) 9.55% 7.84% 6.48% 6.81% 6.16% 3.26%
ROA (Net income/ Total Assets) 3.01% 3.62% 2.34% 2.41% 2.61% 1.56%
Assets 1 2,050 1,809 2,479 2,704 2,509 2,419
Book Value Per Share 2 34.30 37.00 39.50 42.30 44.80 46.30
Cash Flow per Share 2 1.450 0.1600 0.2100 0.2800 0.0800 0.2800
Capex 1 6.21 12.3 9.19 28.8 22 10.4
Capex / Sales 0.18% 0.34% 0.31% 0.82% 0.45% 0.25%
Announcement Date 30/08/18 09/09/19 05/12/20 20/08/21 07/09/22 12/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
AAREY DRUGS & PHARMACEUTICALS LIMITED Stock Aarey Drugs & Pharmaceuticals Limited
-5.62% 16.02M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+50.70% 791B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.96% 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.15% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.77% 328B
ABBVIE INC. Stock AbbVie Inc.
+8.79% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.02% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+1.27% 225B
NOVARTIS AG Stock Novartis AG
+11.95% 218B
AMGEN INC. Stock Amgen Inc.
+3.68% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AAREYDRUGS Stock
  4. Financials Aarey Drugs & Pharmaceuticals Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW